Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease
Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Jul 11, 2021
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into how certain tests and physical signs can help diagnose Wilson disease, a genetic condition that affects how the body processes copper. Researchers want to understand the long-term effects of the disease by studying a large group of patients who have already been diagnosed with it. They are specifically interested in identifying any symptoms or indicators that might be important for better diagnosis and treatment.
To participate in the trial, you need to have a genetic diagnosis of Wilson disease. This means that your doctor has confirmed you have the condition through genetic testing. The trial is currently open for recruitment, and people of all ages are welcome to join, as long as they agree to follow up with the researchers. If you decide to participate, you'll help contribute to important research that could lead to better understanding and management of Wilson disease for current and future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • genetically diagnosed patients with wilson disease
- Exclusion Criteria:
- • Deny follow-up
About Second Affiliated Hospital, School Of Medicine, Zhejiang University
The Second Affiliated Hospital of Zhejiang University School of Medicine is a leading clinical research institution dedicated to advancing healthcare through innovative medical practices and rigorous scientific inquiry. With a robust infrastructure and a multidisciplinary team of experienced researchers and clinicians, the hospital is committed to conducting high-quality clinical trials that address critical health challenges. As an integral part of Zhejiang University, the hospital leverages academic expertise and cutting-edge technology to foster collaboration in research, education, and patient care, ultimately aiming to improve patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hangzhou, Zhejiang, China
Patients applied
Trial Officials
Zhi-Ying Wu
Principal Investigator
Second Affiliated Hospital, Zhejiang University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials